Meta-analysis: Probiotics in antibiotic-associated diarrhoea

Alimentary Pharmacology and Therapeutics

Volumn 35, Issue 12, 2012, Pages 1355-1369

  Videlock, E J ^a   Cremonini, F ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; CLINDAMYCIN; PLACEBO; PROBIOTIC AGENT;

AGE DISTRIBUTION; ANTIBIOTIC ASSOCIATED DIARRHEA; ANTIBIOTIC THERAPY; ARTICLE; BIFIDOBACTERIUM; CLOSTRIDIUM DIFFICILE INFECTION; DEFECATION HABIT; DIARRHEA; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG INDICATION; DRUG INDUCED DISEASE; DRUG SAFETY; ERADICATION THERAPY; HELICOBACTER INFECTION; HIGH RISK POPULATION; HUMAN; LACTOBACILLUS; META ANALYSIS; NUMBERS NEEDED TO TREAT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSEUDOMEMBRANOUS COLITIS; PUBLISHING; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK BENEFIT ANALYSIS; RISK REDUCTION; SACCHAROMYCES BOULARDII; SYSTEMATIC REVIEW; TREATMENT DURATION;

AGE FACTORS; ANTI-BACTERIAL AGENTS; DIARRHEA; HUMANS; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84861201441     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2012.05104.x     Document Type: Article

References (75)

1. McFarland LV,. Epidemiology, risk factors and treatments for antibiotic-associated diarrhea. Dig Dis 1998; 16: 292-307. (Pubitemid 128527395)
2. Food and Agriculture Organization of the United Nations, World Health Organization. Health and Nutritional Properties of Probiotics in Food Including Powder Milk With Live Lactic Acid Bacteria. Text (electronic publication). Cõrdoba, Argentina: Food and Agriculture Organization of the United Nations/World Health Organization, 2001.
3. Shanahan F,. Probiotics in Perspective. Gastroenterology 2010; 139: 1808-12.
4. Jonkers D, Stockbrügger R,. Review article: probiotics in gastrointestinal and liver diseases. Aliment Pharmacol Ther 2007; 26 (Suppl. 2): 133-48. (Pubitemid 350233325)
5. Cremonini F, Di Caro S, Nista EC, et al,. Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. Aliment Pharmacol Ther 2002; 16: 1461-7. (Pubitemid 34953587)
6. McFarland LV,. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. American Journal of Gastroenterology 2006; 101: 812-22.
7. Malfertheiner P, Megraud F, O'Morain C, et al,. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007; 56: 772-81. (Pubitemid 46854190)
8. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P,. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009; 151: 264-9.
9. Lundh A, Gotzsche PC,. Recommendations by Cochrane Review Groups for assessment of the risk of bias in studies. BMC Med Res Methodol 2008; 8: 22.
10. Higgins JPT, Green S, Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Interventions. Chichester, England/Hoboken NJ: Wiley-Blackwell, 2008.
11. The Cochrane Collaboration. Review Manager (RevMan) [Computer Program]. Copenhagen: The Nordic Cochrane Centre, 2011.
12. Cochran W,. The combination of estimates from different experiments. Biometrics 1954; 10: 101-29.
13. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88. (Pubitemid 17189972)
14. Begg CB, Mazumdar M,. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-101.
15. Egger M, Davey Smith G, Schneider M, Minder C,. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34. (Pubitemid 27387172)
16. Armuzzi A, Cremonini F, Ojetti V, et al,. Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study. Digestion 2001; 63: 1-7. (Pubitemid 32098452)
17. Conway S, Hart A, Clark A, Harvey I,. Does eating yogurt prevent antibiotic-associated diarrhoea? A placebo-controlled randomised controlled trial in general practice. Br J Gen Pract 2007; 57: 953-9.
18. De Bortoli N, Leonardi G, Ciancia E, et al,. Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics. Am J Gastroenterol 2007; 102: 951-6. (Pubitemid 46698221)
19. Borgia M, Sepe N, Brancato V, Borgia R,. A controlled clinical study on Streptococcus faecium preparation for the prevention of side reactions during long-term antibiotic treatments. Curr Ther Res 1982; 31: 265-71. (Pubitemid 12183886)
20. Erdeve O, Tiras U, Dallar Y,. The probiotic effect of Saccharomyces boulardii in a pediatric age group. J Trop Pediatr 2004; 50: 234-6. (Pubitemid 39136891)
21. Lionetti E, Miniello VL, Castellaneta SP, et al,. Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in children: a randomized placebo controlled trial. Aliment Pharmacol Ther 2006; 24: 1461-8. (Pubitemid 44657123)
22. Merenstein DJ, Foster J, D'Amico F,. A randomized clinical trial measuring the influence of kefir on antibiotic-associated diarrhea: the measuring the influence of Kefir (MILK) Study. Arch Pediatr Adolesc Med 2009; 163: 750-4.
23. Plewinska EM, Planeta-Malecka I, Bak-Romaniszyn L, Czkwianlanc E, Malecka-Panas E,. Probiotics in the treatment of Helicobacter pylori infection in children. Gastroenterologia Polska 2006; 13: 315-9. (Pubitemid 44386606)
24. Schrezenmeir J, Heller K, McCue M, et al,. Benefits of oral supplementation with and without synbiotics in young children with acute bacterial infections. Clin Pediatr (Phila) 2004; 43: 239-49. (Pubitemid 39090063)
25. Seki H, Shiohara M, Matsumura T, et al,. Prevention of antibiotic-associated diarrhea in children by Clostridium butyricum MIYAIRI. Pediatr Int 2003; 45: 86-90. (Pubitemid 36523566)
26. Sharma JB, Chanana C, Kumar S, Roy K, Malhotra N,. Comparison of ofloxacin & ornidazole with probiotic versus doxycycline & metronidazole for the outpatient treatment of pelvic inflammatory disease. J Med Educ 2007; 9: 66-9. (Pubitemid 350020017)
27. Sheu BS, Cheng HC, Kao AW, et al,. Pretreatment with Lactobacillus- and Bifidobacterium-containing yogurt can improve the efficacy of quadruple therapy in eradicating residual Helicobacter pylori infection after failed triple therapy. Am J Clin Nutr 2006; 83: 864-9.
28. Sheu BS, Wu JJ, Lo CY, et al,. Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther 2002; 16: 1669-75.
29. Siitonen S, Vapaatalo H, Salminen S, et al,. Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea. Ann Med 1990; 22: 57-9. (Pubitemid 20110833)
30. Sykora J, Valeckova KN, Amlerova J, et al,. Effects of a specially designed fermented milk product containing probiotic Lactobacillus casei DN-114 001 and the eradication of H. pylori in children-A prospective randomized double-blind study. J Clin Gastroenterol 2005; 39: 692-8. (Pubitemid 41177089)
31. Szajewska H, Kotowska M, Mrukowicz JZ, Armanska M, Mikolajczyk W,. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J Pediatr 2001; 138: 361-5. (Pubitemid 32207138)
32. Armuzzi A, Cremonini F, Bartolozzi F, et al,. The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 2001; 15: 163-9. (Pubitemid 32142492)
33. Arvola T, Laiho K, Torkkeli S, et al,. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics 1999; 104: e64.
34. Beausoleil M, Fortier N, Guénette S, et al,. Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: a randomized, double-blind, placebo-controlled trial. Can J Gastroenterol 2007; 21: 732-6. (Pubitemid 351166126)
35. Can M, Beşirbellioglu BA, Avci IY, Beker CM, Pahsa A,. Prophylactic Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea: a prospective study. Med Sci Monit 2006; 12: PI19-22.
36. Cimperman L, Bayless G, Best K, et al,. A randomized, double-blind, placebo-controlled pilot study of Lactobacillus reuteri ATCC 55730 for the prevention of antibiotic-associated diarrhea in hospitalized adults. J Clin Gastroenterol 2011; 45: 785-9.
37. Cindoruk M, Erkan G, Karakan T, Dursun A, Unal S,. Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study. Helicobacter 2007; 12: 309-16. (Pubitemid 47196340)
38. Corrêa NBO, Péret Filho LA, Penna FJ, Lima FMLS, Nicoli JR,. A randomized formula controlled trial of Bifidobacterium lactis and Streptococcus thermophilus for prevention of antibiotic-associated diarrhea in infants. J Clin Gastroenterol 2005; 39: 385-9. (Pubitemid 40548075)
39. Cremonini F, Di Caro S, Covino M, et al,. Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am J Gastroenterol 2002; 97: 2744-9. (Pubitemid 35265423)
40. Gao XW, Mubasher M, Fang CY, Reifer C, Miller LE,. Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients. Am J Gastroenterol 2010; 105: 1636-41.
41. Gotz V, Romankiewicz JA, Moss J, Murray HW,. Prophylaxis against ampicillin-associated diarrhea with a lactobacillus preparation. Am J Hosp Pharm 1979; 36: 754-7. (Pubitemid 9199579)
42. Hickson M, D'Souza AL, Muthu N, et al,. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ 2007; 335: 80.
43. Jirapinyo P, Densupsoontorn N, Thamonsiri N, Wongarn R,. Prevention of antibiotic-associated diarrhea in infants by probiotics. J Med Assoc Thai 2002; 85 (Suppl. 2): S739-42. (Pubitemid 35345830)
44. Koning CJM, Jonkers DMAE, Stobberingh EE, Mulder L, Rombouts FM, Stockbrugger RW,. The effect of a multispecies probiotic on the intestinal microbiota and bowel movements in healthy volunteers taking the antibiotic amoxycillin. Am J Gastroenterol 2008; 103: 178-89.
45. Koning CJM, Jonkers D, Smidt H, et al,. The effect of a multispecies probiotic on the composition of the faecal microbiota and bowel habits in chronic obstructive pulmonary disease patients treated with antibiotics. Br J Nutr 2010; 103: 1452-60.
46. Kotowska M, Albrecht P, Szajewska H,. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther 2005; 21: 583-90. (Pubitemid 40381510)
47. La Rosa M, Bottaro G, Gulino N, et al,. Prevention of antibiotic-associated diarrhea with Lactobacillus sporogens and fructo-oligosaccharides in children. A multicentric double-blind vs placebo study. Minerva Pediatr 2003; 55: 447-52. (Pubitemid 37474680)
48. Lewis SJ, Potts LF, Barry RE,. The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients. J Infect 1998; 36: 171-4. (Pubitemid 28165587)
49. Lönnermark E, Friman V, Lappas G, Sandberg T, Berggren A, Adlerberth I,. Intake of Lactobacillus plantarum reduces certain gastrointestinal symptoms during treatment with antibiotics. J Clin Gastroenterol 2010; 44: 106-12.
50. McFarland LV, Surawicz CM, Greenberg RN, et al,. Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. Am J Gastroenterol 1995; 90: 439-48.
51. Myllyluoma E, Veijola L, Ahlroos T, et al,. Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy-a placebo-controlled, double-blind randomized pilot study. Aliment Pharmacol Ther 2005; 21: 1263-72. (Pubitemid 40733493)
52. Nista EC, Candelli M, Cremonini F, et al,. Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. Aliment Pharmacol Ther 2004; 20: 1181-8. (Pubitemid 39657952)
53. Orrhage K, Brismar B, Nord CE,. Effect of supplements with Bifidobacterium longum and Lactobacillus acidophilus on the intestinal microbiota during administration of Clindamycin. Microb Ecol Health Dis 1994; 7: 17-25. (Pubitemid 2040934)
54. Psaradellis E, Sampalis J,. Efficacy of BIO K+ CL1285® in the reduction of antibiotic-associated diarrhea-a placebo controlled double-blind randomized, multi-center study. Arch Med Sci 2010; 6: 56-64.
55. Ruszczyński M, Radzikowski A, Szajewska H,. Clinical trial: effectiveness of Lactobacillus rhamnosus (strains E/N, Oxy and Pen) in the prevention of antibiotic-associated diarrhoea in children. Aliment Pharmacol Ther 2008; 28: 154-61. (Pubitemid 351782820)
56. Safdar N, Barigala R, Said A, McKinley L,. Feasibility and tolerability of probiotics for prevention of antibiotic-associated diarrhoea in hospitalized US military veterans. J Clin Pharm Ther 2008; 33: 663-8.
57. Song HJ, Kim J-Y, Jung S-A, et al,. Effect of probiotic Lactobacillus (Lacidofil® cap) for the prevention of antibiotic-associated diarrhea: a prospective, randomized, double-blind, multicenter study. J Korean Med Sci 2010; 25: 1784-91.
58. Surawicz CM, Elmer GW, Speelman P, McFarland LV, Chinn J, van Belle G,. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology 1989; 96: 981-8. (Pubitemid 19091110)
59. Szajewska H, Albrecht P, Topczewska-Cabanek A,. Randomized, double-blind, placebo-controlled trial: effect of lactobacillus GG supplementation on Helicobacter pylori eradication rates and side effects during treatment in children. J Pediatr Gastroenterol Nutr 2009; 48: 431-6.
60. Szymański H, Armańska M, Kowalska-Duplaga K, Szajewska H,. Bifidobacterium longum PL03, Lactobacillus rhamnosus KL53A, and Lactobacillus plantarum PL02 in the prevention of antibiotic-associated diarrhea in children: a randomized controlled pilot trial. Digestion 2008; 78: 13-7.
61. Tankanow RM, Ross MB, Ertel IJ, Dickinson DG, McCormick LS, Garfinkel JF,. A double-blind, placebo-controlled study of the efficacy of Lactinex in the prophylaxis of amoxicillin-induced diarrhea. DICP 1990; 24: 382-4. (Pubitemid 20138011)
62. Thomas MR, Litin SC, Osmon DR, Corr AP, Weaver AL, Lohse CM,. Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: a randomized, placebo-controlled trial. Mayo Clin Proc 2001; 76: 883-9. (Pubitemid 32825909)
63. Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ,. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr 1999; 135: 564-8. (Pubitemid 30180445)
64. Wenus C, Goll R, Loken EB, Biong AS, Halvorsen DS, Florholmen J,. Prevention of antibiotic-associated diarrhoea by a fermented probiotic milk drink. Eur J Clin Nutr 2008; 62: 299-301. (Pubitemid 351234268)
65. Wunderlich PF, Braun L, Fumagalli I, et al,. Double-blind report on the efficacy of lactic acid-producing Enterococcus SF68 in the prevention of antibiotic-associated diarrhoea and in the treatment of acute diarrhoea. J Int Med Res 1989; 17: 333-8. (Pubitemid 19193537)
66. Bartlett JG,. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 2002; 346: 334-9.
67. Högenauer C, Hammer HF, Krejs GJ, Reisinger EC,. Mechanisms and management of antibiotic-associated diarrhea. Clin Infect Dis 1998; 27: 702-10. (Pubitemid 29244321)
68. O'Mahony C, Scully P, O'Mahony D, et al,. Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-kappaB activation. PLoS Pathog 2008; 4: e1000112.
69. Pothoulakis C, Kelly CP, Joshi MA, et al,. Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum. Gastroenterology 1993; 104: 1108-15. (Pubitemid 23090764)
70. D'Souza AL, Rajkumar C, Cooke J, Bulpitt CJ,. Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 2002; 324: 1361.
71. Adam, J, Barret A, Barret-Bellet C,. Controlled double blind clinical trials of Ultra-Levure: Multicentre study by 25 physicians in 388 cases. Gazette Medicale de France 1977; 84: 2072-8.
72. Witsell DL, Garrett CG, Yarbrough WG, Dorrestein SP, Drake AF, Weissler MC,. Effect of Lactobacillus acidophilus on antibiotic-associated gastrointestinal morbidity: a prospective randomized trial. J Otolaryngol 1995; 24: 230-3.
73. Salminen MK, Rautelin H, Tynkkynen S, et al,. Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clin Infect Dis 2004; 38: 62-9. (Pubitemid 38045874)
74. Sipsas NV, Zonios DI, Kordossis T,. Safety of Lactobacillus strains used as probiotic agents. Clin Infect Dis 2002; 34: 1283-4.
75. Moore RA, Gavaghan DJ, Edwards JE, Wiffen P, McQuay HJ,. Pooling data for number needed to treat: no problems for apples. BMC Med Res Methodol 2002; 2: 2.